| 查看: 1369 | 回复: 10 | |||
[交流]
【求助】关于化学名称pnu类化合物的求助 已有4人参与
|
| 比如化学名称pnu109112代表一特定结构的化合物，其中pnu是什么意思？怎么据此查找其结构式？多谢 |
回复此楼» 猜你喜欢
阿西替尼杂质
已经有0人回复
-
盐酸贝西沙星
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有62人回复
-
姜黄烯杂质
已经有0人回复
-
申博自荐
已经有2人回复
-
克立硼罗
已经有0人回复
-
米拉贝隆
已经有0人回复
-
SPME-GC-O-MS
已经有0人回复
-
请教执业药师报考的一些问题
已经有4人回复
-
祈福面上能中
已经有141人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 求助：怎么根据中文名称或英文名称 写出 化合物的分子式呢？
已经有16人回复
- 求助三种有机化合物名称
已经有7人回复
- 化合物化学名称的唯一性问题
已经有3人回复
- 【求助】含水化合物和带结晶水的化合物是一个概念吗？
已经有8人回复
- 【求助】从一个药品的代号怎么查找该化合物的化学结构？
已经有13人回复
- 求助：中药化学，分离如下化合物（求爱思考者帮解答）有效期至2010年12月31日
已经有5人回复
- 【求助】请问查已知化合物的详细化学性质到哪个网站查询比较全面？
已经有12人回复
- 【求助】安捷伦液相报告如何显示化合物名称？
已经有8人回复
- 【求助】哪个网站可以查化合物的IUPAC名称？
已经有4人回复
- 【求助】关于苯胺类化合物的氧化
已经有13人回复
2楼2010-10-14 13:37:07
gdqabc(金币+1):欢迎讨论 2010-10-24 08:51:15
|
本帖内容被屏蔽 |
3楼2010-10-15 11:05:10
4楼2010-10-15 15:23:47
nkbeholder
木虫 (正式写手)
- DRDEPI: 1
- 应助: 11 (小学生)
- 金币: 2945.1
- 散金: 4
- 红花: 5
- 帖子: 748
- 在线: 303.7小时
- 虫号: 202353
- 注册: 2006-03-01
- 性别: GG
- 专业: 药物化学
5楼2010-10-15 15:55:24
6楼2010-10-15 17:08:45
leonumn
铁杆木虫 (著名写手)
- 应助: 2 (幼儿园)
- 金币: 23565.4
- 散金: 81
- 红花: 2
- 帖子: 1935
- 在线: 204.3小时
- 虫号: 414915
- 注册: 2007-06-28
- 性别: GG
- 专业: 合成药物化学
7楼2010-10-22 09:43:15
leonumn
铁杆木虫 (著名写手)
- 应助: 2 (幼儿园)
- 金币: 23565.4
- 散金: 81
- 红花: 2
- 帖子: 1935
- 在线: 204.3小时
- 虫号: 414915
- 注册: 2007-06-28
- 性别: GG
- 专业: 合成药物化学
8楼2010-10-22 09:46:22
leonumn
铁杆木虫 (著名写手)
- 应助: 2 (幼儿园)
- 金币: 23565.4
- 散金: 81
- 红花: 2
- 帖子: 1935
- 在线: 204.3小时
- 虫号: 414915
- 注册: 2007-06-28
- 性别: GG
- 专业: 合成药物化学
gdqabc(金币+1):欢迎讨论 2010-10-24 08:52:02
|
Activated Sulfonamides are Cleaved by Glutathione-S-Transferases Kenneth A. Koeplinger1, Zhiyang Zhao1,2, Tillie Peterson1, Joseph W. Leone1, Francis S. Schwende2, Robert L. Heinrikson1 and Alfredo G. Tomasselli1 + Author Affiliations 1Protein Science (K.A.K., T.P., J.W.L., R.L.H., A.G.T.) and2Drug Metabolism (Z.Z., F.S.S.), Pharmacia & Upjohn, Incorporated, Kalamazoo, Michigan Next SectionAbstract In preclinical pharmacokinetic studies and in in vitro rat, dog, and human primary hepatocyte incubations, the sulfonamide (-NH-SO2-) bond of a potent inhibitor of the HIV-1 protease containing the p-cyanopyridinyl moiety (PNU-109112), undergoes metabolic cleavage to form the corresponding amine metabolite (PNU-143070). Strikingly, a compound, PNU-140690, obtained by substituting the cyanopyridinyl group of PNU-109112 with a trifluoropyridinyl moiety, was stable under the same in vivo and in vitro conditions used for PNU-109112. The apparent “sulfonamidase activity” present in liver was localized to the cytosolic fraction and shown to be an enzyme-mediated reaction requiring reduced glutathione (GSH). The enzyme responsible was purified in a single step on a GSH immobilized gel and was identified as glutathione-S-transferase (GST) by sequence analysis of peptides obtained by tryptic digestion of the purified protein. Moreover, a mixture of GST isoenzymes purified from rat liver, and three recombinant human GST isoforms, A1–1, M1–1, and P1–1, were active toward PNU-109112 sulfonamide cleavage; the three isoforms exhibited differential rates of PNU-109112 cleavage, demonstrating isoenzyme selectivity. |
9楼2010-10-22 09:46:54
leonumn
铁杆木虫 (著名写手)
- 应助: 2 (幼儿园)
- 金币: 23565.4
- 散金: 81
- 红花: 2
- 帖子: 1935
- 在线: 204.3小时
- 虫号: 414915
- 注册: 2007-06-28
- 性别: GG
- 专业: 合成药物化学
gdqabc(金币+1):欢迎讨论 2010-10-24 08:52:08
|
Targeting the HIV-protease in AIDS therapy: a current clinical perspective1 References and further reading may be available for this article. To view references and further reading you must purchase this article. Alfredo G. Tomasselli and Robert L. Heinrikson2 Department of Protein Science, Pharmacia and Upjohn, Kalamazoo, MI 49001, USA Received 1 November 1999; accepted 1 December 1999. Available online 8 March 2000. Abstract This review deals with clinical applications of compounds that inhibit the action of the protease encoded within the genome of human immunodeficiency virus (HIV). The HIV-protease is essential for viral maturation and represents an important therapeutic target in the fight against AIDS. Following a brief overview of the enzyme structure and function, the article focuses on a number of peptide and non-peptide based HIV-protease inhibitors that are in current clinical use. These drugs are discussed both with respect to their efficacy in treatment of AIDS, and to problems related to insurgence of viral resistance and side effects seen to date in patient populations. |
10楼2010-10-22 09:47:13
28